Translational Neuroendocrinology
101 – 126 of 126
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2006
-
Mark
Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
(
- Contribution to journal › Letter
-
Mark
CART Regulates Islet Hormone Secretion and Is Expressed in the {beta}-Cells of Type 2 Diabetic Rats.
(
- Contribution to journal › Article
- 2005
-
Mark
Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca(2+) channels.
(
- Contribution to journal › Article
-
Mark
Combining neuroprotective treatment of embryonic nigral donor tissue with mild hypothermia of the graft recipient.
(
- Contribution to journal › Article
-
Mark
Proteolysis of NR2B by calpain in the hippocampus of epileptic rats.
(
- Contribution to journal › Article
-
Mark
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
(
- Contribution to journal › Article
- 2004
-
Mark
Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
(
- Contribution to journal › Article
- 2003
-
Mark
Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.
(
- Contribution to journal › Article
- 2002
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
The Gastrin-ECL Cell Axis. Functional Aspects
2002)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
Brain-derived neurotrophic factor inhibits apoptosis and dopamine-induced free radical production in striatal neurons but does not prevent cell death
(
- Contribution to journal › Article
-
Mark
Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors
(
- Contribution to journal › Article
-
Mark
A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control
(
- Contribution to journal › Article
-
Mark
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration
(
- Contribution to journal › Article
-
Mark
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine
(
- Contribution to journal › Article
-
Mark
Huntingtons sjukdom - ännu ett galet protein?
(
- Contribution to journal › Article
-
Mark
Cell-specific processing of chromogranin A in endocrine cells of the rat stomach
(
- Contribution to journal › Article
- 2000
-
Mark
Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor
(
- Contribution to journal › Article
-
Mark
Improving the survival of grafted dopaminergic neurons: a review over current approaches
(
- Contribution to journal › Article
-
Mark
Caspase inhibition increases embryonic striatal graft survival
(
- Contribution to journal › Article
- 1999
-
Mark
Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
(
- Contribution to journal › Article
-
Mark
Graft survival
(
- Contribution to journal › Letter
- « previous
- 1
- 2
- 3
- next »